These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 2167709)
41. Subunit vaccines against exogenous retroviruses: overview and perspectives. Hunsmann G Cancer Res; 1985 Sep; 45(9 Suppl):4691s-4693s. PubMed ID: 2410114 [TBL] [Abstract][Full Text] [Related]
42. Use of lentivirus-like particles alone and in combination with live vaccinia-virus-based vaccines. Panicali DL; Mazzara G; Sullivan JL; Hesselton R; Shen L; Letvin N; Daniel M; Desrosiers R; Stott EJ AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1449. PubMed ID: 1466979 [No Abstract] [Full Text] [Related]
43. Antibody-dependent enhancement and neutralization pattern of sera from SIV-infected or HIV-2-vaccinated rhesus monkeys. Le Grand R; Vogt G; Chapel A; Dormont D J Med Primatol; 1991 Jun; 20(4):172-6. PubMed ID: 1942007 [TBL] [Abstract][Full Text] [Related]
44. Systemic vaccination prevents the total destruction of mucosal CD4 T cells during acute SIV challenge. Mattapallil JJ; Hill B; Douek DC; Roederer M J Med Primatol; 2006 Aug; 35(4-5):217-24. PubMed ID: 16872285 [TBL] [Abstract][Full Text] [Related]
45. Whole inactivated SIV vaccine grown on human cells fails to protect against homologous SIV grown on simian cells. Putkonen P; Nilsson C; Hild K; Benthin R; Cranage M; Aubertin AM; Biberfeld G J Med Primatol; 1993; 22(2-3):100-3. PubMed ID: 8411101 [TBL] [Abstract][Full Text] [Related]
54. AIDS research. New findings cast doubt on UK vaccine trials. Anderson C Nature; 1991 Sep; 353(6342):287. PubMed ID: 1822967 [No Abstract] [Full Text] [Related]
55. HIV-related lentiviruses of nonhuman primates. Desrosiers RC; Daniel MD; Li Y AIDS Res Hum Retroviruses; 1989 Oct; 5(5):465-73. PubMed ID: 2556170 [No Abstract] [Full Text] [Related]
56. Silent infection of macaques inoculated with low-dose SIVmac251/spl. Petry H; Dittmer U; Stahl-Hennig C; Jurkiewicz E; Hunsmann G; Lüke W AIDS Res Hum Retroviruses; 1997 Nov; 13(16):1355-6. PubMed ID: 9359653 [No Abstract] [Full Text] [Related]
57. Vaccination with Rev and Tat against AIDS. Osterhaus AD; van Baalen CA; Gruters RA; Schutten M; Siebelink CH; Hulskotte EG; Tijhaar EJ; Randall RE; van Amerongen G; Fleuchaus A; Erfle V; Sutter G Vaccine; 1999 Jun; 17(20-21):2713-4. PubMed ID: 10418922 [No Abstract] [Full Text] [Related]
58. Progress in vaccines against AIDS. Bolognesi DP Science; 1989 Dec; 246(4935):1233-4. PubMed ID: 2555922 [No Abstract] [Full Text] [Related]
59. ELISA for detection of antibodies to a type D retrovirus, SRV-W. Schultz KT; Thomas C; Toohey K; Curro T Viral Immunol; 1989; 2(1):47-55. PubMed ID: 2545226 [TBL] [Abstract][Full Text] [Related]
60. Strategy for developing a genetically-engineered whole-virus vaccine against HIV. Haynes JR; Yao FL; Ma J; Cao SX; Klein MH Mol Immunol; 1991 Mar; 28(3):231-4. PubMed ID: 2017194 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]